Furkan Meletli

Furkan Meletli

Auto-generated profile, based on publicly available information

Furkan Meletli

Department of Chemistry, Faculty of Science, Marmara University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
FMFurkan Meletli
Furkan Meletli
CGCihan Gündüz
Cihan Gündüz
MAMustafa Muhlis Alparslan
Mustafa Muhlis Alparslan
AAAzade Attar
Azade Attar
SDSerap Demir
Serap Demir
ÖDÖzkan Danış
Özkan Danış

15 August 2025 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
FMFurkan Meletli
Furkan Meletli
BMBengü Sema Mutafoğlu
Bengü Sema Mutafoğlu
MÖMücahit Özdemir
Mücahit Özdemir
BYBahattin Yalçın
Bahattin Yalçın
ÖDÖzkan Danış
Özkan Danış
SDSerap Demir
Serap Demir

2 April 2025 in South African Journal of Botany
Verified
Journal Article
Closed access
EIEce İsKit
Ece İsKit
DADuygu Aktaş
Duygu Aktaş
LÖLalehan Özalp
Lalehan Özalp
FMFurkan Meletli
Furkan Meletli
ÖDÖzkan Danış
Özkan Danış

28 September 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
LOLalehan Ozalp
Lalehan Ozalp
BOBerk Orhan
Berk Orhan
MAMustafa Muhlis Alparslan
Mustafa Muhlis Alparslan
FMFurkan Meletli
Furkan Meletli
EÇEmrah Çakmakçı
Emrah Çakmakçı
ÖDÖzkan Danış
Özkan Danış
A series of arylcoumarin derivatives and two novel biscoumarin derivatives were investigated for their human recombinant glutathione S-transferase P1-1 (GSTP1-1) enzyme inhibitory activities for the first time. 4-(3,4-Dihydroxyphenyl)-6,7-dihydroxycoumarin (compound 24) was observed to be the most active coumarin derivative (IC50: 0.14 mu M). The inhibition was found to be time-dependent and irreversible. Hypothetical binding modes of the ten most active compounds were calculated by molecular docking. Ligand efficiency indices (LEI) were estimated to better understand the binding performance of the coumarin derivatives. Extensive structure-activity relationship studies showed that hydroxy substitution on both the coumarin and the aryl ring enhanced the biological activity and the position of hydroxy group on the coumarin ring is critical for the binding pose and the activity. Top three ligands were subjected to molecular dynamics simulations and MM/PBSA for further investigation. Binding mode of compound 24 suggested that its high inhibitory activity might be attributed to its position between Tyr7 and the cofactor, glutathione (GS-DNB). Exhibiting favorable druglikeness profiles and pharmacokinetics based on ADME studies, compound 5 and 24 can be considered as potential drug leads in future studies for further development.Communicated by Ramaswamy H. Sarma

11 October 2025 in Bioorganic Chemistry
Verified
Journal Article
Closed access
FMFurkan Meletli
Furkan Meletli
AOAyşe Ogan
Ayşe Ogan
RYRefiye Yanardag
Refiye Yanardag
OSOzlem SACAN
Ozlem SACAN

1 December 2025 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AGAhmet Gunes
Ahmet Gunes
FMFurkan Meletli
Furkan Meletli
ODOzkan Danıs
Ozkan Danıs
MAMEHMET SALIH AGIRTAS
MEHMET SALIH AGIRTAS
BYBahattin Yalçın
Bahattin Yalçın
Introduction: In this study, we report on the synthesis and characterization of new silicon (IV) phthalocyanine compounds (SiPcs) axially substituted with coumarin-linked derivatives, designed for potential application in photodynamic therapy (PDT) due to their photophysical properties. Methods: Characterization was carried out using FT-IR, UV-Vis, MALDI-TOF-MS, and 1H NMR spectroscopy. In dimethyl sulfoxide (DMSO), the SiPcs produced singlet oxygen with quantum yields of 0.17 to 0.19, assessed by the DPBF quenching method. DNA binding studies via UV-Vis spectroscopy and molecular docking suggested high binding affinities (ΔG0 values between -9.90 to -10.4 kcal/mol) and stable interactions with calf thymus DNA (ct-DNA). Results: The compounds showed promising inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), with IC50 values indicating higher potency and selectivity compared to galantamine, a known cholinesterase inhibitor. Conclusion: The combined singlet oxygen generation, DNA binding, and enzyme inhibition data underscore the potential of these SiPc-coumarin derivatives as multifunctional agents for PDT and neuroprotective applications such as Alzheimer's disease (AD).